user
menu
letter
Sign InRegister
langEnglisharrow

Galectin-3

Galectin-3

Galectin-3 분자 정보

Molecule Name
Galectin-3
분자 별명
Galectin-3,LGALS3,MAC2,Gal-3,35 kDa lectin,CBP 35,GALBP,IgE-binding protein,L-31,Laminin-binding protein,Lectin L-29,Mac-2 antigen
Drug Development Progress
임상 약물 수7
시판 약물 수1
최고 연구 개발 단계Approved
표적 별명
Galactoside-binding protein，GALBP，Epididymis Secretory Sperm Binding Protein，MAC2，Laminin-binding protein，CBP 35，Gal-3，IgE-binding protein，Carbohydrate-binding protein 35，L-31，Lectin L-29，LGALS3，Advanced Glycation End-Product Receptor 3，Lectin， Galactoside-Binding， Soluble， 3，Galactose-Specific Lectin 3，35 KDa Lectin，Mac-2 Antigen，Galectin-3，LGALS2，CBP35，GALIG，GAL3，L31，Galectin 3，MAC-2
분자 배경
Galectin-3 (Gal-3) is also known as LGALS3, 35 kDa lectin, Carbohydrate-binding protein 35 (CBP 35), Galactose-specific lectin 3, Galactoside-binding protein (GALBP), IgE-binding protein, Laminin-binding protein, Mac-2 antigen, Lectin L-29. Galectin-3 is a member of the lectin family. LGALS3 / Galectin-3 is expressed in the nucleus, cytoplasm, mitochondrion, cell surface, and extracellular space. LGALS3 / Galectin-3 has been shown to be involved in the following biological processes: cell adhesion, cell activation and chemoattraction, cell growth and differentiation, cell cycle, and apoptosis.

Galectin-3 제품 목록

Species
  • Human（3）
Tag
  • His Tag（2）
  • His Tag & Avi Tag（1）
Host
  • HEK293（2）
  • E. coli（1）
Conjugate
  • Unconjugated（2）
  • Biotin-labeled（1）
Grade
  • RUO（3）
Low Endotoxin
  • No（3）
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
Galectin-3
GA3-H5129
Human Galectin-3 Protein, His Tag
Human
E. coli
SDS-PAGE

$340.00

200ug
Galectin-3
GA3-H5247
Human Galectin-3 Protein, His Tag
Human
HEK293
SDS-PAGE

$300.00

100ug
Galectin-3
Avitag
GA3-H82E3
Biotinylated Human Galectin-3 Protein, His,Avitag™
Human
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

제품 문의Request Customization
Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
OlitigaltinGB-0139; TD-139Phase 2 ClinicalLund University Foundation, The University Of Edinburgh
Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis
상세
Galactomannan CGM-CT-01Phase 2 ClinicalGalectin Therapeutics Inc
Bile Duct Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Gallbladder Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Prostatic Neoplasms
상세
SelvigaltinGB-1211; GB1211Phase 2 ClinicalGalecto Inc
Carcinoma, Non-Small-Cell Lung; Hepatic Insufficiency; Melanoma; Metabolic Dysfunction-Associated Steatotic Liver Disease; Multiple Myeloma; Squamous Cell Carcinoma of Head and Neck
상세
ProLectin-MPhase 2 ClinicalBioXyTran Inc
Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Influenza, Human
상세
Gal-400Gal-400Phase 1 ClinicalGalecto Inc
Liver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease
상세
BelapectinGR-MD-02Phase 1 ClinicalGalectin Therapeutics Inc
Carcinoma, Non-Small-Cell Lung; Esophageal and Gastric Varices; Hepatic Insufficiency; Hypertension, Portal; Liver Cirrhosis; Melanoma; Metabolic Dysfunction-Associated Steatotic Liver Disease; Psoriasis; Squamous Cell Carcinoma of Head and Neck
상세
SIF-001SIF001Phase 1 ClinicalSuninflam Inc
Epilepsy; Neuroinflammatory Diseases
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
OcriplasminA-01016; THR-409ApprovedThrombogenicsJetrea, JejetreaUnited StatesVitreomacular AdhesionThrombogenics Inc2012-10-17
Arterial Occlusive Diseases; Diabetic macular oedema; Diabetic Retinopathy; Disease Progression; Eye Diseases; Macular Degeneration; Retinal Diseases; Retinal Vein Occlusion; Stroke; Uveitis; Venous Thrombosis; Vitreomacular Adhesion; Vitreous Detachment
상세
Customer Reviews